Journal Information

Statistics

Follow this link to access the full text of the article

Case Letter
Phototoxic drug eruption induced by vandetanib used for the treatment of metastatic medullary thyroid cancer
Ecem Bostana,
Corresponding author
bostanecem@gmail.com

Corresponding author.
, Duygu Gulserena, Ozay Gokozb
a Department of Dermatology and Venereology, Hacettepe University, Faculty of Medicine, Ankara, Turkey
b Department of Pathology, Hacettepe University, Faculty of Medicine, Ankara, Turkey
Read
4101
Times
was read the article
1701
Total PDF
2400
Total HTML
Share statistics
Article information
ISSN: 03650596
Original language: English
The statistics are updated each day
Year/Month Html Pdf Total
2024 December 63 25 88
2024 November 120 46 166
2024 October 108 68 176
2024 September 164 104 268
2024 August 138 109 247
2024 July 129 100 229
2024 June 100 69 169
2024 May 83 58 141
2024 April 125 86 211
2024 March 116 60 176
2024 February 102 89 191
2024 January 91 47 138
2023 December 61 53 114
2023 November 74 76 150
2023 October 67 70 137
2023 September 70 72 142
2023 August 42 26 68
2023 July 53 25 78
2023 June 56 39 95
2023 May 39 23 62
2023 April 28 17 45
2023 March 36 36 72
2023 February 30 29 59
2023 January 46 38 84
2022 December 68 34 102
2022 November 69 66 135
2022 October 115 63 178
2022 September 104 91 195
2022 August 69 46 115
2022 July 34 36 70
Show all

Follow this link to access the full text of the article

Idiomas
Anais Brasileiros de Dermatologia
en pt
Cookies policy Política de cookies
To improve our services and products, we use "cookies" (own or third parties authorized) to show advertising related to client preferences through the analyses of navigation customer behavior. Continuing navigation will be considered as acceptance of this use. You can change the settings or obtain more information by clicking here. Utilizamos cookies próprios e de terceiros para melhorar nossos serviços e mostrar publicidade relacionada às suas preferências, analisando seus hábitos de navegação. Se continuar a navegar, consideramos que aceita o seu uso. Você pode alterar a configuração ou obter mais informações aqui.